331 related articles for article (PubMed ID: 30502425)
1. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
Liu Y; Wang Y; Zhao J
Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
Hassani Najafabadi A; Abdouss M; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
[TBL] [Abstract][Full Text] [Related]
3. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
4. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
[TBL] [Abstract][Full Text] [Related]
5. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
6. Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.
Shi S; Zhang Z; Luo Z; Yu J; Liang R; Li X; Chen H
Sci Rep; 2015 Jun; 5():11337. PubMed ID: 26067670
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
9. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
[TBL] [Abstract][Full Text] [Related]
10. Improved intestinal absorption and oral bioavailability of astaxanthin using poly (ethylene glycol)-graft-chitosan nanoparticles: preparation, in vitro evaluation, and pharmacokinetics in rats.
Zhu Y; Gu Z; Liao Y; Li S; Xue Y; Firempong MA; Xu Y; Yu J; Smyth HD; Xu X
J Sci Food Agric; 2022 Feb; 102(3):1002-1011. PubMed ID: 34312873
[TBL] [Abstract][Full Text] [Related]
11. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
12. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy.
Kurakula M; El-Helw AM; Sobahi TR; Abdelaal MY
Int J Nanomedicine; 2015; 10():321-34. PubMed ID: 25609947
[TBL] [Abstract][Full Text] [Related]
13. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
14. Effect of PEGylated chitosan as multifunctional stabilizer for deacetyl mycoepoxydience nanosuspension design and stability evaluation.
Du J; Zhou Y; Wang L; Wang Y
Carbohydr Polym; 2016 Nov; 153():471-481. PubMed ID: 27561519
[TBL] [Abstract][Full Text] [Related]
15. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Nanoencapsulation of Sepiapterin within PEG-PCL Nanoparticles by Complexation with Triacetyl-Beta Cyclodextrin.
Kuplennik N; Sosnik A
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357400
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
19. Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy.
Chi C; Zhang C; Liu Y; Nie H; Zhou J; Ding Y
Eur J Pharm Sci; 2020 Mar; 144():105212. PubMed ID: 31923602
[TBL] [Abstract][Full Text] [Related]
20. Polyelectrolyte Complex Nanoparticles Based on Methoxy Poly(Ethylene Glycol)-B-Poly (ε-Caprolactone) Carboxylates and Chitosan for Delivery of Tolbutamide.
Shi Y; Xue J; Liu Z; Du M; Xu L; Sun Q; Liu Z; Shang Q
J Biomater Sci Polym Ed; 2018 Oct; 29(15):1799-1811. PubMed ID: 30141739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]